National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
541
87
105
394
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
4.8%
26 terminated/withdrawn out of 541 trials
93.8%
+7.3% vs industry average
11%
59 trials in Phase 3/4
34%
134 of 394 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (541)
Investigating Clinical Heterogeneity in Immune Checkpoint Inhibitor-induced Inflammatory Arthritis
Role: collaborator
Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires
Role: lead
Studies of the Natural History of Rheumatic Diseases
Role: lead
Systemic Lupus Erythematosus in Gullah Health
Role: collaborator
A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity
Role: lead
Study of Systemic Lupus Erythematosus
Role: lead
Effects of Treatments on Atopic Dermatitis
Role: lead
Algorithm-informed Decision-making to Advance Pain Treatment
Role: collaborator
The Acquisition of Blood and Skin Samples From Normal Volunteers to Support Research Activities on Dermatologic Diseases
Role: lead
The Role of Vitamin K on Knee Osteoarthritis Outcomes
Role: collaborator
Feasibility and Acceptability of PREVAIL (PREserving Valued Activities In Life)
Role: collaborator
The Osteoarthritis Prevention Study
Role: collaborator
Diffuse Cutaneous Scleroderma (DSSc) SFDI Study
Role: collaborator
Agile Development of a Digital Exposure Treatment for Youth With Chronic Musculoskeletal Pain
Role: collaborator
Natural History, Pathogenesis and Outcome of Melorheostosis A Rare Osteosclerotic Disease
Role: lead
Improving Health for Patients With Chronic Low Back Pain in Rural Communities Through Telerehabilitation
Role: collaborator
Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related Conditions
Role: lead
Frequency and Complications of Major Orthopedic Procedures in Medicare Beneficiaries
Role: lead
The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD
Role: lead
FDG PET/MR Imaging of Peripheral Pain Generators
Role: collaborator